All news

8 results out of 19
02 July 2018
Investing in the future with Bpifrance: launch of PSL Innovation Fund
On 29 June Fonds national d'amorçage 2, managed by Bpifrance on behalf of the French State within the framework of the Programme of investments for the future (French acronym: PIA), participated in the launch, by Université Paris sciences et lettres (PSL) and Elaia Partners, of PSL Innovation Fund, a seed fund with a target size of €75mn dedicated to deep tech start-ups.
04 November 2016
The PIA, via Bpifrance, invests in YposKesi beside AFM-Téléthon
AFM-Téléthon and the SPI fund, managed by Bpifrance within the framework of the Program of Investments for the Future (PIA), create YposKesi*, the 1st French pharmaceutical industrial actor dedicated to the production of gene therapy and cellular therapy drugs for the rare diseases.
18 July 2016
Gene therapy: Bpifrance participates in the initial public offering of Gensight
Bpifrance invests €14.5mn in Gensight Biologics on the occasion of its initial public offering on Euronext Paris (1), which allows the company to finance its development on the market of the orphan hereditary illnesses of the retina and of the central nervous system.
12 July 2016
Care of diabetes: the PIA supports the Mellidem project via Bpifrance
The Mellidem project, which aims at developing a French network of excellence in the field of the medical devices to manage diabetes, is granted €11mn within the framework of the Program of investments for the future (PIA) via Bpifrance.
10 November 2015
The PIA, via Bpifrance, invests in Netatmo, a specialist of connected objects
On 5 November, Netatmo, a French company and a specialist of connected objects, announced a €30mn fund raising made in particular with Fonds ambition numérique, managed by Bpifrance within the framework of the Program of investments for the future (PIA).
19 October 2015
The PIA finances the seed-stage and the acceleration of innovative companies via Bpifrance
The PIA participates in a new seed fund of €30.5mn dedicated to the innovative companies in Champagne-Ardenne, Lorraine, Nord-Pas de Calais and Picardy, Fira nord-est, and invests in the acceleration fund Breega Capital Venture One, respectively via the FNA and French Tech Accélération, managed by Bpifrance.
12 October 2015
The PIA, via Bpifrance, invests in AFM-Téléthon biotherapies plant
AFM-Téléthon and Fund SPI, managed by Bpifrance within the framework of the PIA, join to create the biggest European development and production plant for gene and cell therapies to provide the sick with curative therapeutic treatments mass-produced from 2019.
25 September 2015
The PIA, via Bpifrance, supports the development of Vulog and iAdvize
The Program of investments for the future (PIA) supports via Bpifrance the development of two digital service companies, Vulog and iAdvize. To enable them to go on growing, in particular internationally, the PIA participates in their fundraisings of respectively €8.4mn and €14mn.
Haut de page